The biosimilars journey: current status and ongoing challenges

Biosimilar products are already approved and marketed in several countries. The Food and Drug Administration has approved ten different biosimilars, and the European Medicines Agency has approved 40. Even though this scenario has provided important experience with biosimilar products, there are stil...

Descripción completa

Detalles Bibliográficos
Autores principales: Kos, Igor Age, Azevedo, Valderílio Feijó, Neto, Daniel Egg, Kowalski, Sérgio Cândido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172013/
https://www.ncbi.nlm.nih.gov/pubmed/30302115
http://dx.doi.org/10.7573/dic.212543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172013/
https://www.ncbi.nlm.nih.gov/pubmed/30302115
http://dx.doi.org/10.7573/dic.212543

Ejemplares similares